Skip to main content
. 2014 Mar 4;(3):1–115. doi: 10.1002/14651858.CD006404.pub2

Analysis 2.3.

Analysis 2.3.

Comparison 2 Artesunate-pyronaridine versus artemether-lumefantrine; subgroup analysis, Outcome 3 Total failure PCR-adjusted (Day 28); subgrouped by country.